License to Corvus. Genentech hereby grants to Corvus a non-exclusive, worldwide, fully paid, perpetual, sublicensable (as described in Section 6.2(c)) license, under Genentech’s right, title and interest in and to the Genentech Owned Inventions, solely for the purpose of performing [***] for use in the Combination.
Appears in 2 contracts
Samples: Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)
License to Corvus. Genentech hereby grants to Corvus a non-exclusive, worldwide, fully paid, perpetual[***], sublicensable (as described in Section 6.2(c)) license, under Genentech’s right, title and interest in and to the Genentech Owned Inventions[***], solely for the purpose of performing [***] for use in the Combination.
Appears in 2 contracts
Samples: Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)
License to Corvus. Genentech hereby grants to Corvus a non-exclusive, worldwide, fully paid, irrevocable, perpetual, sublicensable (as described in Section 6.2(c6.3(c)(i)) license, license under Genentech’s right, title and interest in and to the Genentech Owned Inventions, Inventions solely for the purpose of performing [***] for use in the Combination.
Appears in 1 contract
Samples: Phase Ib/Ii Combination Study Agreement (Corvus Pharmaceuticals, Inc.)